UVA (> 360-400) and UVB (300-325) specific sunscreens

Abstract

UVB radiation of about 300-310 nm wavelength and UVA radiation of about 380-390 nm wavelength, each of which exists in solar light, induces MMPs (matrix metalloproteinases) in human skin that degrade the collagen of the dermal matrix. This degradation contributes to photoaging of human skin, which can be prevented by blocking these wavelengths of solar radiation. In contrast, diseases that result in the overproduction of collagen can be treated by exposing the affected with to radiation having wavelengths in those regions, for these wavelengths not only induce MMPs but also inhibit collagen biosynthesis. For lighter skinned people so affected, the UVA wavelengths are preferred because of the reduced amount of erythema, whereas dark skinned people can be treated with the UVB radiation because they generally do not suffer from erythema.

Description

RELATED APPLICATIONS [0001] This application is a division based on of Ser. No. 09 / 900535, filed Jul. 6, 2001, now U.S. Pat. No. ______, based on provisional application No. 60 / 216244, filed 6 Jul. 2000, the disclosure of which is incorporated herein by reference.BACKGROUND OF THE INVENTION [0002] 1. Field of the Invention [0003] This invention relates to sunscreens that absorb specific wavelengths that we have found induce destructive enzymes in the skin, and to the use of these specific wavelengths in treating skin conditions. [0004] 2. The State of the Art [0005] With regard to photodamage to skin from the sun, the prevailing view is now that both UVB and UVA radiation should be blocked to prevent damage to the skin. It has been known for some time that UVB, while enabling the skin to produce Vit. D3, nevertheless also produces erythema (sunburn). If the UVB radiation reaches a threshold dose level termed the minimum erythemal dose (MED), then sufficient UVB radiation has been de...

AI Technical Summary

Benefits of technology

The patent text discusses the discovery of specific wavelengths of UVB and UVA radiation that can cause skin damage by inducing matrix metalloproteinases (MMPs) and shutting down collagen biosynthesis. The technical effect of the patent is to provide a sunscreen that blocks these specific wavelengths to protect against skin damage. Additionally, the text explains that UVA radiation can be used to treat fibrotic skin conditions in people with dark skin who are less sensitive to UVB radiation.

Problems solved by technology

While various commercially available UVB blockers adequately filter in this UVB range, those available for blocking UVA are less than desirable for blocking UVA radiation in this wavelength range.

Images